A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
about
Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usageInfection control and cost control in the era of managed care.Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococciClinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaComplex Routes of Nosocomial Vancomycin-Resistant Enterococcus faecium Transmission Revealed by Genome Sequencing.Incidence, clinical characteristics, and outcomes of nosocomial Enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing, China: a four-year retrospective study.Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patientsGastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.Economic impact of antimicrobial resistance.Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unitEffects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococciImpact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.Antimicrobial activity and safety evaluation of Enterococcus faecium KQ 2.6 isolated from peacock feces.Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study.Reference group choice and antibiotic resistance outcomes.Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University Hospitals intensive care units, EgyptDefining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient.Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.Intra-abdominal infections: considerations for the use of the carbapenems.Multicenter study of high-dose daptomycin for treatment of enterococcal infectionsSystematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections.Clinical and economic burden of antimicrobial resistance.Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults.Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.Vancomycin-resistant enterococcal bacteremia pharmacotherapy.Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.Longitudinal Multicenter Analysis of Outcomes After Cessation of Control Measures for Vancomycin-Resistant Enterococci.Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance.The Threat and Response to Infectious Diseases (Revised).Evaluation of the NanoCHIP® Infection Control Panel test for direct detection and screening of methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria and vancomycin-resistant Enterococcus (VRDaptomycin experience in patients with human immunodeficiency virus and resistant gram-positive infections.Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units.Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolatesRisk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation.Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital.
P2860
Q28268161-3F42E53A-A6D4-4B3F-B80A-1A642B108FBFQ30309662-F3B366CD-F50D-473B-B0B2-75620E2258A2Q30309847-361B963D-160A-4F04-A2F0-A280AB83EBCBQ33218606-8F3486A8-9214-413A-AB0A-1F62FCCAF82AQ33258506-7058D788-E5E0-450C-AB92-76ECA91BD9B6Q33688646-EFBAF4A0-9CCB-43E8-B079-08CE4D61AC2BQ33712044-8123E88E-8190-4751-AA5A-45BDE9E19973Q33868715-E146CF9F-5EF7-46BD-9EF1-2F2F1DA7A10FQ33880518-49D62575-D8C9-4A97-81E8-5828B34558C0Q33978474-EEEA9C64-459F-4550-BAFC-5FF2350F9530Q34058125-4365185D-666B-45B4-9DB3-3EF82A157559Q34213712-D0038E7A-39F0-4CB8-93EE-390013A1C38FQ34448163-F50C952A-E9BA-4F16-BDA1-F9E63F770D23Q34645156-1AC5C464-1ADC-4088-BCE1-9E6C572C7D4AQ35027260-E1780621-31F6-4B2F-841D-CB1DDCB6EBF7Q35627143-0BBEF7FF-7BE8-46F9-A692-69C7999E6498Q35809439-79882F20-6914-4F89-BDDF-C13FE96CBF39Q35880537-6EF810D3-7936-49CA-A020-D17682698CDDQ36057341-B6E4AEF0-E9F8-4ADE-8E49-A1A6B2D23700Q36161246-A7C7DADF-16FB-4DF8-9986-7FB5E5029E67Q36382134-9CA8D1DB-BD67-483D-A7B8-895860B42014Q36719679-8EFDCF7D-C16B-4AA0-90C6-B9ED8CF324F2Q37124177-DCA0CDCC-58A7-481D-BE93-7F56BAA375F8Q37263709-F84938D0-8F19-479D-8125-F9D7A7B3CFD1Q37291374-44339BF4-1F35-49F5-A3F9-12C58B9B078AQ37427850-65713B3A-FFC2-4085-928E-54FCA29FD53DQ37539680-C901269D-5BD2-4C83-B537-03232E422294Q38069872-CFDDCBCC-FE55-4138-BC95-D99E8756CC86Q38263421-5975E28A-CA18-4E19-8126-B4603F1052B0Q39910428-17D3ED92-2D93-4BE1-85D6-DD0A098C12E1Q40470230-14529BF7-E0E4-490F-92C5-1105F7C98C2DQ40559892-77708A25-0332-4337-9600-247A11BC907CQ40592880-C521D01B-8FE5-4A22-81DF-F5CD112F5474Q41458740-A6658EFD-2261-45BD-AF32-2F93DEB5EA32Q41699405-1C349DD4-C99F-45E7-96B4-C231C02AE1E1Q41771584-18ECA484-D3D5-49E1-BEFF-80F2FD677100Q41908608-CBBE9D12-D2F4-49BF-93DE-C7940300C4C0Q42202379-89201F0D-D210-4543-BF2E-A5C16CF49365Q42218821-DCE84EE5-041F-4A56-8871-087011B41E12Q42652229-CF2C720E-8342-49C9-ABE1-29E109A55262
P2860
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
A nationwide, multicenter, cas ...... tible enterococcal bacteremia.
@en
A nationwide, multicenter, cas ...... tible enterococcal bacteremia.
@nl
type
label
A nationwide, multicenter, cas ...... tible enterococcal bacteremia.
@en
A nationwide, multicenter, cas ...... tible enterococcal bacteremia.
@nl
prefLabel
A nationwide, multicenter, cas ...... tible enterococcal bacteremia.
@en
A nationwide, multicenter, cas ...... tible enterococcal bacteremia.
@nl
P2093
P1476
A nationwide, multicenter, cas ...... tible enterococcal bacteremia.
@en
P2093
Bhavnani SM
Biedenbach DJ
Deinhart JA
P304
P356
10.1016/S0732-8893(99)00136-4
P577
2000-03-01T00:00:00Z